This article has been updated to include additional comments from Arrayjet.
Arrayjet has tapped GMI to service and support its customers in the US and Canada, the company said this week.
The acquired assets include instruments that are part of the Roche NimbleGen microarray workflow, such as the 4- and-12-bay NimbleGen Hybridization Systems.
The Roslin, UK-based firm, which sells instruments and software for printing arrays, has entered into a non-exclusive co-marketing arrangement with MDS. American Medical Link, meantime, has agreed to support and service Arrayjet instruments in the US and Canada.
The activities are part of Kreatech's makeover from a biotech specializing in FISH probes and labeling kits, to a molecular diagnostics company with expertise in oncology, hematology, and constitutional disorders.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
